Product image of Metformin Hexal (Metformin Hydrochloride) supplied by GNH India

Metformin Hexal

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Hexal (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Hexal, is a biguanide presented as a tablet for oral use. It lowers elevated blood glucose by reducing hepatic glucose production and enhancing peripheral insulin sensitivity, and is indicated for adults with type 2 diabetes mellitus.

All batches are manufactured under EU GMP standards and undergo rigorous quality testing before release. The product is distributed through a secure cold‑chain logistics network to ensure integrity during transport. GNH India supplies Metformin Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hexal Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metformin Hexal acts on glucose metabolism pathways to improve glycemic control in type 2 diabetes mellitus.
  • Type 2 diabetes mellitus: lowers fasting plasma glucose and HbA1c levels.
  • Type 2 diabetes mellitus (adjunct therapy): enhances overall glycemic control when combined with other oral agents or insulin.
  • Type 2 diabetes mellitus (initial monotherapy): can be used as first‑line oral treatment in newly diagnosed patients.

How It Works

  • Metformin Hydrochloride penetrates hepatocytes and activates AMP‑activated protein kinase (AMPK), which suppresses gluconeogenic gene expression, thereby decreasing hepatic glucose output. It also improves peripheral insulin sensitivity by enhancing glucose uptake in muscle and adipose tissue, without stimulating insulin secretion.

Side Effects

Metformin Hexal may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools, especially during dose titration.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration in taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: gradual decrease with long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: rare but life‑threatening metabolic acidosis.
  • Severe hypoglycemia: usually when combined with insulin or sulfonylureas.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Allergic reactions: rash, pruritus, or angioedema.
  • Pancreatitis: inflammation of the pancreas.
  • Metabolic acidosis: non‑lactic acid accumulation.

Precautions & Warnings

  • Metformin Hexal requires careful patient assessment and monitoring.
  • Renal function assessment: evaluate eGFR before initiation and periodically thereafter.
  • Hepatic impairment: avoid use in patients with significant liver disease.
  • Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia or acidosis.
  • Blood glucose monitoring: adjust dose based on fasting and post‑prandial glucose levels.
  • Vitamin B12 monitoring: check levels during long‑term therapy.
  • Pregnancy and lactation: weigh potential benefits against risks.
  • Store at ambient temperature: keep in original container, protect from moisture.

Avoid Interactions

Metformin Hexal can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis.
  • Cimetidine: can increase metformin plasma concentrations.
  • Alcohol excess: heightens risk of lactic acidosis.
  • Carbonic anhydrase inhibitors (e.g., acetazolamide): may reduce renal clearance.
  • High‑dose vitamin B12 supplements: may mask deficiency.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may blunt hypoglycemia symptoms.
  • Diuretics (thiazides): can raise blood glucose.
  • ACE inhibitors/ARBs: monitor renal function and electrolytes.
  • Sulfonylureas: increased risk of hypoglycemia.
  • Corticosteroids: may elevate glucose levels.
  • Thyroid hormones: adjust dose based on metabolic changes.

Frequently Asked Questions

Metformin Hexal is prescribed to improve blood‑sugar control in adults with type 2 diabetes mellitus. It helps lower fasting glucose and HbA1c levels by reducing liver glucose production and increasing insulin sensitivity in muscle and fat tissues.

Metformin Hydrochloride activates AMP‑activated protein kinase (AMPK) in liver cells, which suppresses gluconeogenesis and reduces hepatic glucose output. It also enhances peripheral glucose uptake, improving insulin sensitivity without stimulating insulin secretion.

The specific dose of Metformin Hexal is determined by the prescribing clinician based on individual patient factors such as renal function, glycemic targets, and tolerability. Dosage adjustments are made during treatment to achieve optimal blood‑glucose control.

Safety data for Metformin Hexal in pregnancy and lactation are limited. It may be used when the potential benefits outweigh possible risks, but the decision should be made by a healthcare professional after evaluating maternal and fetal considerations.

To order Metformin Hexal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin Hexal belongs to the biguanide class and is generally first‑line therapy because it does not cause hypoglycemia when used alone and may promote modest weight loss. In contrast, sulfonylureas stimulate insulin release and carry a higher hypoglycemia risk, while newer agents like SGLT2 inhibitors have different mechanisms and side‑effect profiles.

Metformin Hexal should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Metformin Hexal is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The prescribing clinician will advise the appropriate dosing schedule and whether the medication should be taken once or twice daily.

The most serious adverse events linked to Metformin Hexal are lactic acidosis—a rare but potentially fatal metabolic disturbance—and severe hypoglycemia when combined with insulin or sulfonylureas. Long‑term therapy may also lead to vitamin B12 deficiency, which should be monitored periodically.

Metformin Hexal is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, significant hepatic disease, or a history of lactic acidosis. It should also be avoided in individuals with known hypersensitivity to metformin or other biguanides.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT